Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05224843 · ClinicalTrials.gov registry record · Phase 1
Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT05224843: Completed Phase 1 study, sponsored by Yale University.
NCT05224843 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 80 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05224843, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
To test an interactive intervention to screen for Elder Abuse and Mistreatment (EM) in the Primary Care (PC) setting to promote self-identification and self-disclosure of EM.
Primary Outcome
Participation will be determined by the number of patients enrolled in VOICES. Successful enrollment of 80 older adults (N=80).
Interventions
- BEHAVIORAL Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-12-17 |
| Est. Completion | 2022-06-22 |
| Phase | Phase 1 |
What the finished NCT05224843 record still lists
NCT05224843 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (33% higher).
The record links to 0 conditions, and to 1 intervention - of which Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) is the first listed.
NCT05224843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05224843 about?
NCT05224843 is a clinical study titled "Feasibility of VOICES Elder Abuse Intervention in Primary Care Setting (VOICES-PC Feasibility)". To test an interactive intervention to screen for Elder Abuse and Mistreatment (EM) in the Primary Care (PC) setting to promote self-identification and self-disclosure of EM.
What is the current status of trial NCT05224843?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2021-12-17. Estimated completion is 2022-06-22.
What interventions are being tested in trial NCT05224843?
The interventions under investigation include: Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05224843?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05224843's enrollment target sits among peer trials
80 672nd of 2000 higher than 1,305 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI